Endocrinology
| T1D
Endocrinology
T1D

Racial Differences in Technology Use Among Patients with Type 1 Diabetes in a Safety-Net Hospital

book_2 Source: ENDO Online 2020 - Oral Session
calendar_today Published on Medfyle: June 2020
import_contacts 7 min
headphones 3 min

In this medfyle

Expert commentary by Raghu G. Mirmira, MD, PhD

This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.

Acknowledgements
Read more arrow_downward Hide arrow_upward

This is a highlights summary of an oral session given at the ENDO Online 2020 and presented by:

Kathryn Fantasia, MD
Section of Endocrinology, Diabetes, and Nutrition, Dept. of Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA

The content is produced by Infomedica, the official reporting partner of ENDO Online 2020. The summary text was drafted by Patrick Moore, PhD, and reviewed by Marco Gallo, MD, an independent external expert, and approved by Raghu Mirmira, MD, PhD, the scientific editor of the program.

The presenting authors of the original session had no part in the creation of this conference highlights summary.

In addition, an expert commentary on the topic has been provided by:

Raghu G. Mirmira, MD, PhD
Professor and Director
Translational Research Center
Department of Medicine
The University of Chicago

About the Expert
Read more arrow_downward Hide arrow_upward

Raghu G. Mirmira, MD, PhD
Professor and Director
Translational Research Center
Department of Medicine
The University of Chicago
 

Raghavendra (Raghu) Mirmira, MD, PhD, is a professor of Medicine in the Section of Endocrinology, Diabetes & Metabolism, and director of the newly established Translational Research Center. Prof. Mirmira is an international leader in Type 1 diabetes research—specifically the biology of islet cells. His work set the foundation for the development of ultra-rapid- and ultra-long-acting insulin that are widely in use today to treat all forms of diabetes.

As director of the Department of Medicine’s Translational Research Center, Prof. Mirima will facilitate and oversee the recruitment and support of outstanding physician scientists in strategic areas of priority to further advance our translational research. Prof. Mirmira will also become actively involved in the Kovler Diabetes Center and Diabetes Research & Training Center under direction of Louis Philipson, MD, PhD, and Graeme Bell, PhD, respectively.

As a scholar he has published over 140 scientific papers in prestigious journals. In addition, he is deputy editor-in-chief of the Journal of Clinical Endocrinology and Metabolism, and an elected member of the American Society for Clinical Investigation.


Feedback